Merck
Merck has provided details on its latest developments
Published in Lab Business Week, January 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Merck.
Report 1: Merck KGaA and Glenmark Pharmaceuticals S.A, Switzerland, a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL), have entered into an agreement for Glenmark's DPPIV inhibitor GRC 8200, a treatment for type 2 diabetes in phase 2 of clinical development.
The transaction is expected to close this year upon approval of the exclusive license to GRC 8200 by the U.S. antitrust agencies under the HSR act.
Under the agreement, Merck KGaA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-01-14)
More Articles from Lab Business Week
- Antisense Technology
Research from Abbott Laboratories in antisense technology provides new insights - Business Update
Barr confirms generic Thalomid capsule application - Business Update
Paladin, Auxilium sign exclusive distribution agreement for Testim - Cell Biology
Cold Spring Harbor Laboratory describes research in cell biology - Depression
New findings from Pelvipharm Laboratories in the area of depression published - Depression
Research findings from Cold Spring Harbor Laboratory update understanding of depression - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
